Your browser doesn't support javascript.
Prehabilitation and heart failure: main outcomes in the COVID-19 era.
Giovannini, S; Coraci, D; Loreti, C; Castelli, L; Di Caro, F; Fiori, M; Imperia, L M; Madathil, G G; Padua, L; Santagada, D A; Biscotti, L; Bernabei, R.
  • Giovannini S; Department of Geriatrics and Orthopaedics, Università Cattolica del Sacro Cuore, Rome, Italy. letizia.castelli@policlinicogemelli.it.
Eur Rev Med Pharmacol Sci ; 26(11): 4131-4139, 2022 06.
Article in English | MEDLINE | ID: covidwho-1904141
ABSTRACT

OBJECTIVE:

The advent of the SARS-CoV-2 pandemic has resulted in an increase in sedentary behavior, with consequences on cardiopulmonary capacity, especially in the elderly population. Prehabilitation is a strategy usually used before a surgical procedure to improve functional capacity; however, it can be used for non-surgical patients and not in the acute phase of disease. The purpose of this study is to evaluate the effectiveness of a prehabilitation program, using telerehabilitation, in frail elderly patients with chronic heart failure. PATIENTS AND

METHODS:

This is a randomized, controlled, single-blind study. Fifteen patients with chronic heart failure were randomized into three groups two active groups (telerehabilitation and in-person) and the control group. Patients in the active groups underwent a rehabilitation program divided into two 4-week periods, for 45-60 minutes per day, 2 days per week.

RESULTS:

In the Study Group, the quality of life significantly improved (EQoL-5D), and between the two groups a statistically significant difference in the motor dimension of SF-36 was identified.

CONCLUSIONS:

The telerehabilitation prehabilitation program for patients with chronic heart failure was confirmed to be effective and not inferior to a prehabilitation program performed in-person, avoiding the worsening of some domains of quality of life and motor performance, and leading to the improvement of others.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Failure Type of study: Experimental Studies / Randomized controlled trials Limits: Aged / Humans Language: English Journal: Eur Rev Med Pharmacol Sci Journal subject: Pharmacology / Toxicology Year: 2022 Document Type: Article Affiliation country: Eurrev_202206_28986

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Failure Type of study: Experimental Studies / Randomized controlled trials Limits: Aged / Humans Language: English Journal: Eur Rev Med Pharmacol Sci Journal subject: Pharmacology / Toxicology Year: 2022 Document Type: Article Affiliation country: Eurrev_202206_28986